TIDMSPI
RNS Number : 9219S
Spire Healthcare Group PLC
19 March 2021
Spire Healthcare Group plc
19 March 2021
The following replaces the 'Director/PDMR Shareholding'
announcement released on 18 March 2021 at 15.31 under RNS No
7717S.
As previously released the announcement contained incorrect
figures.
The full amended text is shown below.
Notification of Transactions of Persons Discharging Managerial
Responsibilities
This notification is made in accordance with DTR 3.1.4R (1) (a)
of the Disclosure and Transparency Rules.
Grant of Deferred Share Bonus Plan (DSBP) Awards
Spire Healthcare Group plc (the Company) announces that on 18
March 2021, awards (the DSBP Awards) were granted over the
Company's ordinary shares in the form of nil-cost options to the
Directors named below, under the Spire Healthcare Group plc
Deferred Share Bonus Plan.
Under the DSBP, Executive Directors are required to defer a
proportion of their gross cash bonus, received in respect of the
full year ended 31 December 2020, into shares in the Company for a
period of three years. The Directors listed below have the
following interest in shares as deferred share bonus awards under
the DSBP:
Director Percentage deferral Deferred Shares
of 2020 gross cash
bonus*
Justin Ash 50% 97,251
Jitesh Sodha 33% 41,637
* To be disclosed in the 2020 Annual Report and Accounts
The share price used to determine the number of Deferred Shares
subject to award was 166.0 pence, being the mid-market closing
share price on 17 March 2021 (the dealing day prior to the awards
being made).
The DSBP Awards will vest on the third anniversary of the grant
date on 18 March 2024, subject to continued employment. Upon
vesting, the options will remain exercisable until 17 March
2031.
Grant of 2020 Long Term Incentive Plan (LTIP) awards
The Company further announces that, on 18 March 2021, a
performance share award was granted over the Company's ordinary
shares in the form of nil cost options to the following Executive
Directors and PDMR in the Company, under the rules of the Spire
Healthcare Group plc Long Term Incentive Plan.
Executive Director Maximum number of shares under Award
Justin Ash 665,606
Jitesh Sodha 447,843
Other PDMRs
John Forrest 231,918
The number of shares set out above represents 175% of each
Executive Director's base salary and 100% of John Forrest's base
salary. It is the maximum number which may vest under the LTIP
Awards following the end of the performance period (31 December
2024). The shareholder-approved Remuneration Policy permits awards
of up to 200% of base salary.
The actual number of shares which vest will depend on the extent
to which the relevant performance conditions have been
satisfied.
The performance conditions applicable to the LTIP Awards will be
based as follows:
-- 35% on relative total shareholder return (TSR) performance;
-- 35% on ROCE performance; and
-- 30% on two Operational Excellence measures.
Further details of these performance conditions will be
disclosed in the 2020 Annual Report and Accounts when
published.
The share price used to determine the number of shares under the
LTIP Awards was 164.1 pence being the average of the mid-market
closing share price over the five trading days ending on 17 March
2021.
The transaction place is London.
Notes:
1) As previously disclosed, Justin Ash and Jitesh Sodha also
have interests in awards granted under the DSBP during 2020.
Details of these will be included in the Company's 2020 Annual
Report and Accounts.
2) The 2021 LTIP awards described above will also be subject to
a further two-year holding period following the vesting date.
3) As previously disclosed, Justin Ash, Jitesh Sodha and John
Forrest also have interests in awards granted under the LTIP during
2019 and 2020. Details of these for Justin Ash and Jitesh Sodha
will be included in the Company's 2020 Annual Report and
Accounts.
4) The actual number of shares which vest will depend on the
extent to which the relevant performance conditions are satisfied
in due course.
Name of contact and telephone number for queries:
Philip Davies
Company Secretary
Spire Healthcare Group plc
Tel: 07803 508348
The following disclosure is made in accordance with Article 19
of the EU Market Abuse Regulation 596/2014.
a) Name Justin Ash
------------------------------------- --------------------------------------------
2 Reason for the notification
-----------------------------------------------------------------------------------
a) Position/status Chief Executive Officer/PDMR
------------------------------------- --------------------------------------------
b) Initial notification Initial notification
/Amendment
------------------------------------- --------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-----------------------------------------------------------------------------------
a) Name Spire Healthcare Group plc
------------------------------------- --------------------------------------------
b) LEI 213800IBJPW3SE2RA350
------------------------------------- --------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-----------------------------------------------------------------------------------
a) Description of Ordinary shares of 1 pence each
the financial
instrument, type GB00BNLPYF73
of instrument
Identification
code
------------------------------------- --------------------------------------------
b) Nature of the Grant of performance share awards under
transaction the Company's Deferred Share Bonus Plan
------------------------------------- --------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
------------------------------------- -------------------- ----------------------
Nil 97,251
--------------------------------------------------------------- ----------------------
d) Aggregated information As above
- Aggregated volume
- Price
------------------------------------- --------------------------------------------
e) Date of the transaction 2021-03-18
------------------------------------- --------------------------------------------
f) Place of the transaction XLON
------------------------------------- --------------------------------------------
a) Name Jitesh Sodha
------------------------------------- --------------------------------------------
2 Reason for the notification
-----------------------------------------------------------------------------------
a) Position/status Chief Financial Officer/PDMR
------------------------------------- --------------------------------------------
b) Initial notification Initial notification
/Amendment
------------------------------------- --------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-----------------------------------------------------------------------------------
a) Name Spire Healthcare Group plc
------------------------------------- --------------------------------------------
b) LEI 213800IBJPW3SE2RA350
------------------------------------- --------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-----------------------------------------------------------------------------------
a) Description of Ordinary shares of 1 pence each
the financial
instrument, type GB00BNLPYF73
of instrument
Identification
code
------------------------------------- --------------------------------------------
b) Nature of the Grant of performance share awards under
transaction the Company's Deferred Share Bonus Plan
------------------------------------- --------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
------------------------------------- -------------------- ----------------------
Nil 41,637
--------------------------------------------------------------- ----------------------
d) Aggregated information As above
- Aggregated volume
- Price
------------------------------------- --------------------------------------------
e) Date of the transaction 2021-03-18
------------------------------------- --------------------------------------------
f) Place of the transaction XLON
------------------------------------- --------------------------------------------
a) Name Justin Ash
------------------------------------- -------------------------------------------
2 Reason for the notification
----------------------------------------------------------------------------------
a) Position/status Chief Executive Officer/PDMR
------------------------------------- -------------------------------------------
b) Initial notification Initial notification
/Amendment
------------------------------------- -------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------------
a) Name Spire Healthcare Group plc
------------------------------------- -------------------------------------------
b) LEI 213800IBJPW3SE2RA350
------------------------------------- -------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
----------------------------------------------------------------------------------
a) Description of Ordinary shares of 1 pence each
the financial
instrument, type GB00BNLPYF73
of instrument
Identification
code
------------------------------------- -------------------------------------------
b) Nature of the Grant of performance share awards under
transaction the Company's Long Term Incentive Plan
------------------------------------- -------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
------------------------------------- -------------------- ---------------------
Nil 665,606
--------------------------------------------------------------- ---------------------
d) Aggregated information As above
- Aggregated volume
- Price
------------------------------------- -------------------------------------------
e) Date of the transaction 2021-03-18
------------------------------------- -------------------------------------------
f) Place of the transaction XLON
------------------------------------- -------------------------------------------
a) Name Jitesh Sodha
------------------------------------- -------------------------------------------
2 Reason for the notification
----------------------------------------------------------------------------------
a) Position/status Chief Financial Officer/PDMR
------------------------------------- -------------------------------------------
b) Initial notification Initial notification
/Amendment
------------------------------------- -------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------------
a) Name Spire Healthcare Group plc
------------------------------------- -------------------------------------------
b) LEI 213800IBJPW3SE2RA350
------------------------------------- -------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
----------------------------------------------------------------------------------
a) Description of Ordinary shares of 1 pence each
the financial
instrument, type GB00BNLPYF73
of instrument
Identification
code
------------------------------------- -------------------------------------------
b) Nature of the Grant of performance share awards under
transaction the Company's Long Term Incentive Plan
------------------------------------- -------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
------------------------------------- -------------------- ---------------------
Nil 447,843
--------------------------------------------------------------- ---------------------
d) Aggregated information As above
- Aggregated volume
- Price
------------------------------------- -------------------------------------------
e) Date of the transaction 2021-03-18
------------------------------------- -------------------------------------------
f) Place of the transaction XLON
------------------------------------- -------------------------------------------
a) Name John Forrest
2 Reason for the notification
----------------------------------------------------------------------------------
a) Position/status Chief Operating Officer/PDMR
------------------------------------- -------------------------------------------
b) Initial notification Initial notification
/Amendment
------------------------------------- -------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------------
a) Name Spire Healthcare Group plc
------------------------------------- -------------------------------------------
b) LEI 213800IBJPW3SE2RA350
------------------------------------- -------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
----------------------------------------------------------------------------------
a) Description of Ordinary shares of 1 pence each
the financial
instrument, type GB00BNLPYF73
of instrument
Identification
code
------------------------------------- -------------------------------------------
b) Nature of the Grant of performance share awards under
transaction the Company's Long Term Incentive Plan
------------------------------------- -------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
------------------------------------- -------------------- ---------------------
Nil 231,918
--------------------------------------------------------------- ---------------------
d) Aggregated information As above
- Aggregated volume
- Price
------------------------------------- -------------------------------------------
e) Date of the transaction 2021-03-18
------------------------------------- -------------------------------------------
f) Place of the transaction XLON
------------------------------------- -------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHJLMFTMTTBBTB
(END) Dow Jones Newswires
March 19, 2021 12:36 ET (16:36 GMT)
Spire Healthcare (LSE:SPI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Spire Healthcare (LSE:SPI)
Historical Stock Chart
From Apr 2023 to Apr 2024
